title: The effects of insulin and short-term hyperglycaemia on myocardial blood flow in young men with uncomplicated Type I diabetes.
abstract: OBJECTIVE
  Insulin enhances coronary vasodilation in healthy subjects. We tested whether insulin is able to induce coronary vasodilation in Type I (insulin-dependent) diabetic mellitus patients. Additionally, the effect of short-term hyperglycaemia on myocardial perfusion was studied.
  
  
  METHODS
  Myocardial blood flow was quantitated basally and during adenosine infusion (140 microg/kg per min i.v.) with or without simultaneous insulin infusion (1 mU/kg per min for 60 min) in nine non-smoking Type I diabetic males (HbA(1c) 7.4+/-1.0%) without diabetic complications and 10 healthy non-diabetic otherwise matched males using positron emission tomography and (15)O-water. Diabetic patients were studied on two occasions, once during normoglycaemia (plasma glucose ~6 mmol/l) and once during hyperglycaemia (approximately 10 mmol/l) induced by reducing the dose of insulin for two days.
  
  
  RESULTS
  Resting myocardial blood flow was similar in the studied groups (NS). Hyperaemic adenosine stimulated flow was 23% lower in diabetic than in non-diabetic subjects (3.09+/-0.72 vs 4.0+/-1.13 ml x g(-1) x min(-1), p<0.05). Insulin increased significantly adenosine stimulated flow by 23% in diabetic and 17% in non-diabetic subjects (NS between the groups). Hyperglycaemia for two days had no effect on flow values when compared to the values during normoglycaemia (NS).
  
  
  CONCLUSIONS
  Insulin has similar vasodilative effects on coronary arteries in diabetic and non-diabetic subjects. Short-term hyperglycaemia does not alter myocardial blood flow or abolish insulin induced vasodilation in these patients. Insulin induced coronary vasodilation might contribute to the known beneficial effect of intensive insulin therapy on myocardial ischaemia in diabetic patients.
authors.affiliation: Turku PET Centre, Department of Medicine, University of Turku, Turku, Finland. jan.sundell@utu.fi
authors.forename: J
authors.initials: J
authors.lastname: Sundell
authors.forename: H
authors.initials: H
authors.lastname: Laine
authors.forename: P
authors.initials: P
authors.lastname: Nuutila
authors.forename: T
authors.initials: T
authors.lastname: Rönnemaa
authors.forename: M
authors.initials: M
authors.lastname: Luotolahti
authors.forename: O
authors.initials: O
authors.lastname: Raitakari
authors.forename: J
authors.initials: J
authors.lastname: Knuuti
mesh_terms: D000241:Adenosine / Q000494:pharmacology; D000328:Adult; D003326:Coronary Circulation / Q000187:drug effects / Q000502:physiology*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000503:physiopathology*; D006801:Humans; D006943:Hyperglycemia / Q000503:physiopathology*; D007262:Infusions, Intravenous; D007328:Insulin / Q000008:administration & dosage / Q000494:pharmacology*; D008297:Male; D012016:Reference Values; D012039:Regional Blood Flow / Q000187:drug effects
chemical_list: D007328:Insulin; D000241:Adenosine